nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Hydroxyurea—head and neck cancer	0.243	0.449	CbGbCtD
Ropivacaine—CYP1A2—Fluorouracil—head and neck cancer	0.113	0.208	CbGbCtD
Ropivacaine—CYP2D6—Vinblastine—head and neck cancer	0.0861	0.159	CbGbCtD
Ropivacaine—CYP3A4—Vinblastine—head and neck cancer	0.0547	0.101	CbGbCtD
Ropivacaine—CYP3A4—Docetaxel—head and neck cancer	0.0451	0.0833	CbGbCtD
Ropivacaine—Electrocardiogram ST segment—Fluorouracil—head and neck cancer	0.0445	0.106	CcSEcCtD
Ropivacaine—Prothrombin level decreased—Docetaxel—head and neck cancer	0.0158	0.0378	CcSEcCtD
Ropivacaine—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.00917	0.0219	CcSEcCtD
Ropivacaine—Ileus—Vinblastine—head and neck cancer	0.00903	0.0216	CcSEcCtD
Ropivacaine—Application site reaction—Fluorouracil—head and neck cancer	0.00894	0.0214	CcSEcCtD
Ropivacaine—Neurotoxicity—Docetaxel—head and neck cancer	0.00781	0.0187	CcSEcCtD
Ropivacaine—Lidocaine—EGFR—head and neck cancer	0.00723	1	CrCbGaD
Ropivacaine—Phlebitis—Vinblastine—head and neck cancer	0.00538	0.0129	CcSEcCtD
Ropivacaine—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00498	0.0119	CcSEcCtD
Ropivacaine—Leukocytosis—Fluorouracil—head and neck cancer	0.00446	0.0107	CcSEcCtD
Ropivacaine—Dysarthria—Fluorouracil—head and neck cancer	0.00443	0.0106	CcSEcCtD
Ropivacaine—Ileus—Docetaxel—head and neck cancer	0.00428	0.0102	CcSEcCtD
Ropivacaine—Pleural effusion—Docetaxel—head and neck cancer	0.00395	0.00946	CcSEcCtD
Ropivacaine—Coma—Fluorouracil—head and neck cancer	0.00383	0.00917	CcSEcCtD
Ropivacaine—Breast disorder—Hydroxyurea—head and neck cancer	0.00382	0.00915	CcSEcCtD
Ropivacaine—Rigors—Docetaxel—head and neck cancer	0.00371	0.00887	CcSEcCtD
Ropivacaine—Depression—Vinblastine—head and neck cancer	0.00356	0.00853	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00352	0.00843	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0035	0.00838	CcSEcCtD
Ropivacaine—Myocardial infarction—Vinblastine—head and neck cancer	0.0035	0.00838	CcSEcCtD
Ropivacaine—Dysuria—Hydroxyurea—head and neck cancer	0.00342	0.00818	CcSEcCtD
Ropivacaine—Oliguria—Docetaxel—head and neck cancer	0.00328	0.00786	CcSEcCtD
Ropivacaine—Drowsiness—Hydroxyurea—head and neck cancer	0.00326	0.0078	CcSEcCtD
Ropivacaine—Amnesia—Fluorouracil—head and neck cancer	0.00324	0.00775	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00319	0.00764	CcSEcCtD
Ropivacaine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00319	0.00764	CcSEcCtD
Ropivacaine—Respiratory failure—Docetaxel—head and neck cancer	0.00308	0.00738	CcSEcCtD
Ropivacaine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00304	0.00728	CcSEcCtD
Ropivacaine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00303	0.00724	CcSEcCtD
Ropivacaine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00303	0.00724	CcSEcCtD
Ropivacaine—Injection site reaction—Docetaxel—head and neck cancer	0.00301	0.0072	CcSEcCtD
Ropivacaine—Hallucination—Hydroxyurea—head and neck cancer	0.00291	0.00697	CcSEcCtD
Ropivacaine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00289	0.00693	CcSEcCtD
Ropivacaine—Neuropathy—Docetaxel—head and neck cancer	0.00284	0.0068	CcSEcCtD
Ropivacaine—Chills—Hydroxyurea—head and neck cancer	0.00263	0.00628	CcSEcCtD
Ropivacaine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00259	0.0062	CcSEcCtD
Ropivacaine—Anaemia—Vinblastine—head and neck cancer	0.00258	0.00618	CcSEcCtD
Ropivacaine—Phlebitis—Docetaxel—head and neck cancer	0.00255	0.0061	CcSEcCtD
Ropivacaine—Erythema—Hydroxyurea—head and neck cancer	0.00255	0.00609	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00253	0.00604	CcSEcCtD
Ropivacaine—Malaise—Vinblastine—head and neck cancer	0.00252	0.00603	CcSEcCtD
Ropivacaine—Vertigo—Vinblastine—head and neck cancer	0.00251	0.006	CcSEcCtD
Ropivacaine—Convulsion—Vinblastine—head and neck cancer	0.00242	0.00579	CcSEcCtD
Ropivacaine—Hypertension—Vinblastine—head and neck cancer	0.00241	0.00577	CcSEcCtD
Ropivacaine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00236	0.00565	CcSEcCtD
Ropivacaine—Anaemia—Hydroxyurea—head and neck cancer	0.00235	0.00563	CcSEcCtD
Ropivacaine—Discomfort—Vinblastine—head and neck cancer	0.00235	0.00562	CcSEcCtD
Ropivacaine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00232	0.00555	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00231	0.00553	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.0023	0.0055	CcSEcCtD
Ropivacaine—Myocardial infarction—Fluorouracil—head and neck cancer	0.0023	0.0055	CcSEcCtD
Ropivacaine—Malaise—Hydroxyurea—head and neck cancer	0.0023	0.0055	CcSEcCtD
Ropivacaine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00228	0.00546	CcSEcCtD
Ropivacaine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00223	0.00534	CcSEcCtD
Ropivacaine—Convulsion—Hydroxyurea—head and neck cancer	0.00221	0.00528	CcSEcCtD
Ropivacaine—Discomfort—Hydroxyurea—head and neck cancer	0.00214	0.00513	CcSEcCtD
Ropivacaine—Rhinitis—Fluorouracil—head and neck cancer	0.00211	0.00505	CcSEcCtD
Ropivacaine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0021	0.00501	CcSEcCtD
Ropivacaine—Infection—Hydroxyurea—head and neck cancer	0.00207	0.00494	CcSEcCtD
Ropivacaine—Paraesthesia—Vinblastine—head and neck cancer	0.00205	0.0049	CcSEcCtD
Ropivacaine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00204	0.00487	CcSEcCtD
Ropivacaine—Skin disorder—Hydroxyurea—head and neck cancer	0.00202	0.00483	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00201	0.0048	CcSEcCtD
Ropivacaine—Breast disorder—Docetaxel—head and neck cancer	0.00199	0.00475	CcSEcCtD
Ropivacaine—Cramp muscle—Docetaxel—head and neck cancer	0.00198	0.00473	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00198	0.00473	CcSEcCtD
Ropivacaine—Constipation—Vinblastine—head and neck cancer	0.00195	0.00466	CcSEcCtD
Ropivacaine—Pain—Vinblastine—head and neck cancer	0.00195	0.00466	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00194	0.00464	CcSEcCtD
Ropivacaine—Arrhythmia—Fluorouracil—head and neck cancer	0.00188	0.0045	CcSEcCtD
Ropivacaine—Feeling abnormal—Vinblastine—head and neck cancer	0.00188	0.00449	CcSEcCtD
Ropivacaine—Bronchospasm—Docetaxel—head and neck cancer	0.00187	0.00447	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00186	0.00446	CcSEcCtD
Ropivacaine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00185	0.00443	CcSEcCtD
Ropivacaine—Somnolence—Hydroxyurea—head and neck cancer	0.00185	0.00442	CcSEcCtD
Ropivacaine—Erythema—Fluorouracil—head and neck cancer	0.00183	0.00439	CcSEcCtD
Ropivacaine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00183	0.00438	CcSEcCtD
Ropivacaine—Abdominal pain—Vinblastine—head and neck cancer	0.0018	0.00431	CcSEcCtD
Ropivacaine—Pain—Hydroxyurea—head and neck cancer	0.00178	0.00425	CcSEcCtD
Ropivacaine—Constipation—Hydroxyurea—head and neck cancer	0.00178	0.00425	CcSEcCtD
Ropivacaine—Vision blurred—Fluorouracil—head and neck cancer	0.00173	0.00413	CcSEcCtD
Ropivacaine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00171	0.0041	CcSEcCtD
Ropivacaine—Anaemia—Fluorouracil—head and neck cancer	0.00169	0.00405	CcSEcCtD
Ropivacaine—Hypersensitivity—Vinblastine—head and neck cancer	0.00168	0.00402	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00167	0.00399	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00166	0.00397	CcSEcCtD
Ropivacaine—Myocardial infarction—Docetaxel—head and neck cancer	0.00166	0.00397	CcSEcCtD
Ropivacaine—Jaundice—Docetaxel—head and neck cancer	0.00165	0.00395	CcSEcCtD
Ropivacaine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00164	0.00393	CcSEcCtD
Ropivacaine—Asthenia—Vinblastine—head and neck cancer	0.00164	0.00391	CcSEcCtD
Ropivacaine—Convulsion—Fluorouracil—head and neck cancer	0.00159	0.0038	CcSEcCtD
Ropivacaine—Chest pain—Fluorouracil—head and neck cancer	0.00156	0.00373	CcSEcCtD
Ropivacaine—Myalgia—Fluorouracil—head and neck cancer	0.00156	0.00373	CcSEcCtD
Ropivacaine—Diarrhoea—Vinblastine—head and neck cancer	0.00156	0.00373	CcSEcCtD
Ropivacaine—Discomfort—Fluorouracil—head and neck cancer	0.00154	0.00369	CcSEcCtD
Ropivacaine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00153	0.00366	CcSEcCtD
Ropivacaine—Rhinitis—Docetaxel—head and neck cancer	0.00152	0.00365	CcSEcCtD
Ropivacaine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00151	0.00362	CcSEcCtD
Ropivacaine—Confusional state—Fluorouracil—head and neck cancer	0.00151	0.00361	CcSEcCtD
Ropivacaine—Dizziness—Vinblastine—head and neck cancer	0.00151	0.00361	CcSEcCtD
Ropivacaine—Urinary tract disorder—Docetaxel—head and neck cancer	0.0015	0.00359	CcSEcCtD
Ropivacaine—Oedema peripheral—Docetaxel—head and neck cancer	0.0015	0.00358	CcSEcCtD
Ropivacaine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0015	0.00358	CcSEcCtD
Ropivacaine—Asthenia—Hydroxyurea—head and neck cancer	0.00149	0.00357	CcSEcCtD
Ropivacaine—Urethral disorder—Docetaxel—head and neck cancer	0.00149	0.00357	CcSEcCtD
Ropivacaine—Infection—Fluorouracil—head and neck cancer	0.00149	0.00356	CcSEcCtD
Ropivacaine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00146	0.00351	CcSEcCtD
Ropivacaine—Tachycardia—Fluorouracil—head and neck cancer	0.00146	0.00349	CcSEcCtD
Ropivacaine—Vomiting—Vinblastine—head and neck cancer	0.00145	0.00347	CcSEcCtD
Ropivacaine—Headache—Vinblastine—head and neck cancer	0.00143	0.00342	CcSEcCtD
Ropivacaine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00142	0.0034	CcSEcCtD
Ropivacaine—Cardiac disorder—Docetaxel—head and neck cancer	0.00141	0.00338	CcSEcCtD
Ropivacaine—Hypotension—Fluorouracil—head and neck cancer	0.0014	0.00335	CcSEcCtD
Ropivacaine—Dizziness—Hydroxyurea—head and neck cancer	0.00137	0.00329	CcSEcCtD
Ropivacaine—Chills—Docetaxel—head and neck cancer	0.00136	0.00326	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00136	0.00326	CcSEcCtD
Ropivacaine—Arrhythmia—Docetaxel—head and neck cancer	0.00136	0.00325	CcSEcCtD
Ropivacaine—Nausea—Vinblastine—head and neck cancer	0.00135	0.00324	CcSEcCtD
Ropivacaine—Insomnia—Fluorouracil—head and neck cancer	0.00135	0.00324	CcSEcCtD
Ropivacaine—Paraesthesia—Fluorouracil—head and neck cancer	0.00134	0.00321	CcSEcCtD
Ropivacaine—Dyspnoea—Fluorouracil—head and neck cancer	0.00133	0.00319	CcSEcCtD
Ropivacaine—Mental disorder—Docetaxel—head and neck cancer	0.00133	0.00319	CcSEcCtD
Ropivacaine—Somnolence—Fluorouracil—head and neck cancer	0.00133	0.00318	CcSEcCtD
Ropivacaine—Erythema—Docetaxel—head and neck cancer	0.00132	0.00317	CcSEcCtD
Ropivacaine—Vomiting—Hydroxyurea—head and neck cancer	0.00132	0.00316	CcSEcCtD
Ropivacaine—Dyspepsia—Fluorouracil—head and neck cancer	0.00132	0.00315	CcSEcCtD
Ropivacaine—Rash—Hydroxyurea—head and neck cancer	0.00131	0.00314	CcSEcCtD
Ropivacaine—Dermatitis—Hydroxyurea—head and neck cancer	0.00131	0.00313	CcSEcCtD
Ropivacaine—Headache—Hydroxyurea—head and neck cancer	0.0013	0.00312	CcSEcCtD
Ropivacaine—Back pain—Docetaxel—head and neck cancer	0.00128	0.00306	CcSEcCtD
Ropivacaine—Pain—Fluorouracil—head and neck cancer	0.00128	0.00306	CcSEcCtD
Ropivacaine—Muscle spasms—Docetaxel—head and neck cancer	0.00127	0.00304	CcSEcCtD
Ropivacaine—Nausea—Hydroxyurea—head and neck cancer	0.00123	0.00295	CcSEcCtD
Ropivacaine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00123	0.00295	CcSEcCtD
Ropivacaine—Anaemia—Docetaxel—head and neck cancer	0.00122	0.00293	CcSEcCtD
Ropivacaine—Urticaria—Fluorouracil—head and neck cancer	0.00119	0.00284	CcSEcCtD
Ropivacaine—Syncope—Docetaxel—head and neck cancer	0.00119	0.00284	CcSEcCtD
Ropivacaine—Body temperature increased—Fluorouracil—head and neck cancer	0.00118	0.00283	CcSEcCtD
Ropivacaine—Loss of consciousness—Docetaxel—head and neck cancer	0.00116	0.00278	CcSEcCtD
Ropivacaine—Cough—Docetaxel—head and neck cancer	0.00115	0.00276	CcSEcCtD
Ropivacaine—Convulsion—Docetaxel—head and neck cancer	0.00115	0.00274	CcSEcCtD
Ropivacaine—Hypertension—Docetaxel—head and neck cancer	0.00114	0.00273	CcSEcCtD
Ropivacaine—Arthralgia—Docetaxel—head and neck cancer	0.00113	0.0027	CcSEcCtD
Ropivacaine—Chest pain—Docetaxel—head and neck cancer	0.00113	0.0027	CcSEcCtD
Ropivacaine—Myalgia—Docetaxel—head and neck cancer	0.00113	0.0027	CcSEcCtD
Ropivacaine—Hypersensitivity—Fluorouracil—head and neck cancer	0.0011	0.00264	CcSEcCtD
Ropivacaine—Confusional state—Docetaxel—head and neck cancer	0.00109	0.00261	CcSEcCtD
Ropivacaine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00108	0.00258	CcSEcCtD
Ropivacaine—Infection—Docetaxel—head and neck cancer	0.00107	0.00257	CcSEcCtD
Ropivacaine—Shock—Docetaxel—head and neck cancer	0.00106	0.00254	CcSEcCtD
Ropivacaine—Pruritus—Fluorouracil—head and neck cancer	0.00106	0.00253	CcSEcCtD
Ropivacaine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00106	0.00253	CcSEcCtD
Ropivacaine—Tachycardia—Docetaxel—head and neck cancer	0.00105	0.00252	CcSEcCtD
Ropivacaine—Skin disorder—Docetaxel—head and neck cancer	0.00105	0.00251	CcSEcCtD
Ropivacaine—Diarrhoea—Fluorouracil—head and neck cancer	0.00102	0.00245	CcSEcCtD
Ropivacaine—Hypotension—Docetaxel—head and neck cancer	0.00101	0.00241	CcSEcCtD
Ropivacaine—Dizziness—Fluorouracil—head and neck cancer	0.000989	0.00237	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000984	0.00235	CcSEcCtD
Ropivacaine—Insomnia—Docetaxel—head and neck cancer	0.000977	0.00234	CcSEcCtD
Ropivacaine—Paraesthesia—Docetaxel—head and neck cancer	0.00097	0.00232	CcSEcCtD
Ropivacaine—Dyspnoea—Docetaxel—head and neck cancer	0.000963	0.0023	CcSEcCtD
Ropivacaine—Somnolence—Docetaxel—head and neck cancer	0.00096	0.0023	CcSEcCtD
Ropivacaine—Vomiting—Fluorouracil—head and neck cancer	0.000951	0.00228	CcSEcCtD
Ropivacaine—Dyspepsia—Docetaxel—head and neck cancer	0.000951	0.00227	CcSEcCtD
Ropivacaine—Rash—Fluorouracil—head and neck cancer	0.000943	0.00226	CcSEcCtD
Ropivacaine—Dermatitis—Fluorouracil—head and neck cancer	0.000943	0.00226	CcSEcCtD
Ropivacaine—Headache—Fluorouracil—head and neck cancer	0.000937	0.00224	CcSEcCtD
Ropivacaine—Constipation—Docetaxel—head and neck cancer	0.000923	0.00221	CcSEcCtD
Ropivacaine—Pain—Docetaxel—head and neck cancer	0.000923	0.00221	CcSEcCtD
Ropivacaine—Feeling abnormal—Docetaxel—head and neck cancer	0.00089	0.00213	CcSEcCtD
Ropivacaine—Nausea—Fluorouracil—head and neck cancer	0.000889	0.00213	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000883	0.00211	CcSEcCtD
Ropivacaine—Abdominal pain—Docetaxel—head and neck cancer	0.000854	0.00204	CcSEcCtD
Ropivacaine—Body temperature increased—Docetaxel—head and neck cancer	0.000854	0.00204	CcSEcCtD
Ropivacaine—Hypersensitivity—Docetaxel—head and neck cancer	0.000796	0.0019	CcSEcCtD
Ropivacaine—Asthenia—Docetaxel—head and neck cancer	0.000775	0.00185	CcSEcCtD
Ropivacaine—Pruritus—Docetaxel—head and neck cancer	0.000764	0.00183	CcSEcCtD
Ropivacaine—Diarrhoea—Docetaxel—head and neck cancer	0.000739	0.00177	CcSEcCtD
Ropivacaine—Dizziness—Docetaxel—head and neck cancer	0.000714	0.00171	CcSEcCtD
Ropivacaine—Vomiting—Docetaxel—head and neck cancer	0.000687	0.00164	CcSEcCtD
Ropivacaine—Rash—Docetaxel—head and neck cancer	0.000681	0.00163	CcSEcCtD
Ropivacaine—Dermatitis—Docetaxel—head and neck cancer	0.00068	0.00163	CcSEcCtD
Ropivacaine—Headache—Docetaxel—head and neck cancer	0.000677	0.00162	CcSEcCtD
Ropivacaine—Nausea—Docetaxel—head and neck cancer	0.000641	0.00153	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—CEBPA—head and neck cancer	0.000328	0.00988	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CEBPA—head and neck cancer	0.000317	0.00953	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CEBPA—head and neck cancer	0.000317	0.00953	CbGpPWpGaD
Ropivacaine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000304	0.00915	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0003	0.00902	CbGpPWpGaD
Ropivacaine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000293	0.0088	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—MAPK3—head and neck cancer	0.000289	0.0087	CbGpPWpGaD
Ropivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000281	0.00844	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—MAPK1—head and neck cancer	0.000275	0.00828	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—EGFR—head and neck cancer	0.000275	0.00828	CbGpPWpGaD
Ropivacaine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000269	0.00811	CbGpPWpGaD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000267	0.00802	CbGpPWpGaD
Ropivacaine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000255	0.00768	CbGpPWpGaD
Ropivacaine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000235	0.00706	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—MAPK3—head and neck cancer	0.000234	0.00704	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000226	0.0068	CbGpPWpGaD
Ropivacaine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000226	0.00679	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—MAPK3—head and neck cancer	0.000224	0.00673	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CEBPA—head and neck cancer	0.000223	0.0067	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—MAPK1—head and neck cancer	0.000222	0.00669	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—head and neck cancer	0.000222	0.00669	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—MAPK3—head and neck cancer	0.000215	0.00646	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—MAPK3—head and neck cancer	0.000215	0.00646	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000215	0.00645	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—MAPK1—head and neck cancer	0.000213	0.0064	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—head and neck cancer	0.000213	0.0064	CbGpPWpGaD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000212	0.00637	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—MAPK3—head and neck cancer	0.000207	0.00623	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—MAPK3—head and neck cancer	0.000207	0.00623	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—MAPK1—head and neck cancer	0.000204	0.00615	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—MAPK1—head and neck cancer	0.000204	0.00615	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—head and neck cancer	0.000204	0.00615	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—head and neck cancer	0.000204	0.00615	CbGpPWpGaD
Ropivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000199	0.00599	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000199	0.00597	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000197	0.00594	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—MAPK1—head and neck cancer	0.000197	0.00593	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—MAPK1—head and neck cancer	0.000197	0.00593	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—head and neck cancer	0.000197	0.00593	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—head and neck cancer	0.000197	0.00593	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000195	0.00585	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000174	0.00523	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000156	0.0047	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000156	0.0047	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000156	0.0047	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000149	0.00449	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000148	0.00444	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000147	0.00443	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000146	0.0044	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.000146	0.00438	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NOTCH1—head and neck cancer	0.000141	0.00424	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.000139	0.00417	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.000139	0.00417	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000137	0.00413	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000135	0.00407	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000126	0.0038	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000125	0.00375	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000121	0.00364	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000121	0.00363	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000116	0.0035	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—VEGFA—head and neck cancer	0.000115	0.00347	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000115	0.00345	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NOTCH1—head and neck cancer	0.000114	0.00343	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MAPK3—head and neck cancer	0.000109	0.00329	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NOTCH1—head and neck cancer	0.000109	0.00328	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NOTCH1—head and neck cancer	0.000105	0.00315	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NOTCH1—head and neck cancer	0.000105	0.00315	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000104	0.00314	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MAPK1—head and neck cancer	0.000104	0.00313	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—head and neck cancer	0.000104	0.00313	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000102	0.00308	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NOTCH1—head and neck cancer	0.000101	0.00304	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NOTCH1—head and neck cancer	0.000101	0.00304	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	9.81e-05	0.00295	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.75e-05	0.00293	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	9.74e-05	0.00293	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.62e-05	0.00289	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	9.61e-05	0.00289	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—head and neck cancer	9.34e-05	0.00281	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	9.29e-05	0.0028	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	9.24e-05	0.00278	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	9.11e-05	0.00274	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	8.97e-05	0.0027	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—head and neck cancer	8.93e-05	0.00269	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	8.84e-05	0.00266	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MAPK3—head and neck cancer	8.84e-05	0.00266	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.69e-05	0.00261	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	8.61e-05	0.00259	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—head and neck cancer	8.58e-05	0.00258	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—head and neck cancer	8.58e-05	0.00258	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MAPK3—head and neck cancer	8.45e-05	0.00254	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MAPK1—head and neck cancer	8.41e-05	0.00253	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—head and neck cancer	8.41e-05	0.00253	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—HRAS—head and neck cancer	8.35e-05	0.00251	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—head and neck cancer	8.28e-05	0.00249	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—head and neck cancer	8.28e-05	0.00249	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—head and neck cancer	8.24e-05	0.00248	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—STAT3—head and neck cancer	8.16e-05	0.00246	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—UROD—head and neck cancer	8.13e-05	0.00244	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MAPK3—head and neck cancer	8.12e-05	0.00244	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MAPK3—head and neck cancer	8.12e-05	0.00244	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MAPK1—head and neck cancer	8.04e-05	0.00242	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—head and neck cancer	8.04e-05	0.00242	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.9e-05	0.00238	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MAPK3—head and neck cancer	7.83e-05	0.00236	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MAPK3—head and neck cancer	7.83e-05	0.00236	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MAPK3—head and neck cancer	7.8e-05	0.00235	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MAPK1—head and neck cancer	7.73e-05	0.00232	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MAPK1—head and neck cancer	7.73e-05	0.00232	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—head and neck cancer	7.72e-05	0.00232	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—head and neck cancer	7.72e-05	0.00232	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MAPK1—head and neck cancer	7.45e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MAPK1—head and neck cancer	7.45e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—head and neck cancer	7.45e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—head and neck cancer	7.45e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MAPK1—head and neck cancer	7.42e-05	0.00223	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—head and neck cancer	7.42e-05	0.00223	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	7.32e-05	0.0022	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	7.1e-05	0.00214	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	6.77e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—head and neck cancer	6.75e-05	0.00203	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	6.68e-05	0.00201	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—head and neck cancer	6.67e-05	0.00201	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—head and neck cancer	6.6e-05	0.00199	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	6.59e-05	0.00198	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	6.59e-05	0.00198	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	6.59e-05	0.00198	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—head and neck cancer	6.46e-05	0.00194	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	6.42e-05	0.00193	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—head and neck cancer	6.38e-05	0.00192	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6.33e-05	0.00191	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—head and neck cancer	6.31e-05	0.0019	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK3—head and neck cancer	6.31e-05	0.0019	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—head and neck cancer	6.2e-05	0.00187	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—head and neck cancer	6.2e-05	0.00187	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—head and neck cancer	6.13e-05	0.00184	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—head and neck cancer	6.13e-05	0.00184	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—head and neck cancer	6.06e-05	0.00182	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—head and neck cancer	6.06e-05	0.00182	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK3—head and neck cancer	6.03e-05	0.00181	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK1—head and neck cancer	6e-05	0.00181	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—head and neck cancer	6e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—head and neck cancer	5.98e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—head and neck cancer	5.98e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—head and neck cancer	5.96e-05	0.00179	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—head and neck cancer	5.91e-05	0.00178	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—head and neck cancer	5.91e-05	0.00178	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—head and neck cancer	5.85e-05	0.00176	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—head and neck cancer	5.85e-05	0.00176	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—head and neck cancer	5.82e-05	0.00175	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK3—head and neck cancer	5.79e-05	0.00174	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK3—head and neck cancer	5.79e-05	0.00174	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK1—head and neck cancer	5.74e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—head and neck cancer	5.74e-05	0.00173	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	5.74e-05	0.00173	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	5.66e-05	0.0017	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—UROD—head and neck cancer	5.65e-05	0.0017	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK3—head and neck cancer	5.59e-05	0.00168	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK3—head and neck cancer	5.59e-05	0.00168	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK1—head and neck cancer	5.51e-05	0.00166	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK1—head and neck cancer	5.51e-05	0.00166	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—head and neck cancer	5.51e-05	0.00166	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—head and neck cancer	5.51e-05	0.00166	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK3—head and neck cancer	5.5e-05	0.00166	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.44e-05	0.00164	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.36e-05	0.00161	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK1—head and neck cancer	5.32e-05	0.0016	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK1—head and neck cancer	5.32e-05	0.0016	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—head and neck cancer	5.32e-05	0.0016	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—head and neck cancer	5.32e-05	0.0016	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.29e-05	0.00159	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—head and neck cancer	5.26e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK1—head and neck cancer	5.24e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—head and neck cancer	5.24e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—head and neck cancer	4.82e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—UROD—head and neck cancer	4.78e-05	0.00144	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—head and neck cancer	4.61e-05	0.00139	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.43e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—head and neck cancer	4.43e-05	0.00133	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—head and neck cancer	4.43e-05	0.00133	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.37e-05	0.00131	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—head and neck cancer	4.27e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—head and neck cancer	4.27e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—head and neck cancer	4.25e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—head and neck cancer	4.2e-05	0.00127	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.2e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	4.15e-05	0.00125	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.14e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—head and neck cancer	4.11e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—head and neck cancer	4.07e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	3.93e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—head and neck cancer	3.91e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—head and neck cancer	3.91e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—head and neck cancer	3.77e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—head and neck cancer	3.77e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	3.74e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—head and neck cancer	3.74e-05	0.00112	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.71e-05	0.00112	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—UROD—head and neck cancer	3.69e-05	0.00111	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NAT2—head and neck cancer	3.37e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—head and neck cancer	3e-05	0.000903	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DPYD—head and neck cancer	2.96e-05	0.00089	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—YAP1—head and neck cancer	2.81e-05	0.000845	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—head and neck cancer	2.65e-05	0.000797	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NAT2—head and neck cancer	2.34e-05	0.000706	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.11e-05	0.000635	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.09e-05	0.000628	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DPYD—head and neck cancer	2.06e-05	0.000619	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NAT2—head and neck cancer	1.99e-05	0.000598	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.95e-05	0.000587	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.74e-05	0.000524	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TYMS—head and neck cancer	1.69e-05	0.000507	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.67e-05	0.000501	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.65e-05	0.000497	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPX1—head and neck cancer	1.6e-05	0.00048	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.58e-05	0.000475	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.53e-05	0.000461	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.34e-05	0.000404	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.28e-05	0.000384	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.24e-05	0.000374	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.17e-05	0.000353	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.000348	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.11e-05	0.000334	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.00033	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.08e-05	0.000326	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TYMS—head and neck cancer	9.93e-06	0.000299	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTM1—head and neck cancer	9.81e-06	0.000295	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPX1—head and neck cancer	9.4e-06	0.000283	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—head and neck cancer	9.39e-06	0.000283	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	9.3e-06	0.00028	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTEN—head and neck cancer	8.19e-06	0.000247	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TYMS—head and neck cancer	7.66e-06	0.00023	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.64e-06	0.00023	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.57e-06	0.000228	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPX1—head and neck cancer	7.25e-06	0.000218	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.18e-06	0.000216	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—head and neck cancer	6.53e-06	0.000196	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	5.78e-06	0.000174	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTEN—head and neck cancer	5.69e-06	0.000171	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.53e-06	0.000166	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTEN—head and neck cancer	4.82e-06	0.000145	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—head and neck cancer	4.72e-06	0.000142	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.27e-06	0.000128	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.02e-06	0.000121	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.72e-06	0.000112	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.4e-06	0.000102	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—head and neck cancer	3.28e-06	9.87e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.78e-06	8.36e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.63e-06	7.9e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.15e-06	6.46e-05	CbGpPWpGaD
